Renaissance Technologies - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 195 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$180,222
+20.9%
6,614,871
-1.3%
0.31%
+42.8%
Q2 2023$149,074
+1.4%
6,699,971
-1.3%
0.22%
+10.3%
Q1 2023$147,030
-0.7%
6,788,069
-6.9%
0.20%
-3.9%
Q4 2022$148,037
-99.9%
7,288,871
+1.3%
0.20%
-22.2%
Q3 2022$184,543,000
-0.9%
7,197,471
-8.1%
0.26%
+18.1%
Q2 2022$186,289,000
+6.5%
7,833,871
+0.8%
0.22%
+7.8%
Q1 2022$174,992,000
+10.1%
7,770,516
-3.2%
0.20%
+3.5%
Q4 2021$158,868,000
-2.1%
8,023,616
-2.7%
0.20%
-5.7%
Q3 2021$162,318,000
-13.4%
8,247,841
-3.2%
0.21%
-10.3%
Q2 2021$187,488,000
-10.2%
8,522,196
-2.9%
0.23%
-10.0%
Q1 2021$208,729,000
-14.6%
8,773,796
-6.1%
0.26%
-1.9%
Q4 2020$244,374,000
+46.2%
9,341,496
-2.8%
0.26%
+58.7%
Q3 2020$167,192,000
+11.4%
9,605,996
+7.7%
0.17%
+28.5%
Q2 2020$150,034,000
+52.0%
8,919,996
+7.4%
0.13%
+35.4%
Q1 2020$98,721,000
+5.0%
8,302,841
+6.9%
0.10%
+33.3%
Q4 2019$93,995,000
+1.9%
7,768,214
+19.1%
0.07%
-7.7%
Q3 2019$92,220,000
+47.9%
6,524,209
+16.7%
0.08%
+41.8%
Q2 2019$62,334,000
+5.0%
5,590,509
+10.5%
0.06%
+1.9%
Q1 2019$59,379,000
-4.4%
5,057,809
+8.8%
0.05%
-20.6%
Q4 2018$62,087,000
+0.3%
4,647,209
+5.2%
0.07%
+6.2%
Q3 2018$61,907,000
-58.0%
4,415,600
-51.7%
0.06%
-20.0%
Q2 2018$147,245,000
+86.5%
9,143,900
+90.6%
0.08%
-7.0%
Q1 2018$78,935,000
-11.8%
4,798,500
-3.1%
0.09%
-13.1%
Q4 2017$89,478,000
+26.3%
4,954,500
+35.0%
0.10%
+19.3%
Q3 2017$70,826,000
+123.7%
3,669,755
+36.8%
0.08%
+107.5%
Q2 2017$31,664,000
+55.5%
2,683,400
+44.4%
0.04%
+42.9%
Q1 2017$20,369,000
+86.1%
1,858,500
+23.3%
0.03%
+64.7%
Q4 2016$10,944,000
+200.7%
1,507,500
+169.2%
0.02%
+183.3%
Q3 2016$3,640,000
+114.6%
560,000
+80.3%
0.01%
+100.0%
Q2 2016$1,696,000
+89.3%
310,600
+62.3%
0.00%
+50.0%
Q1 2016$896,000
-60.9%
191,400
-58.4%
0.00%
-60.0%
Q4 2015$2,293,000
+34.9%
460,400
+1.8%
0.01%
+25.0%
Q3 2015$1,700,000
-43.6%
452,200
-9.9%
0.00%
-42.9%
Q2 2015$3,015,000
+872.6%
501,614
+805.4%
0.01%
+600.0%
Q1 2015$310,00055,4000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,946,732$165,263,0007.72%
S&T BANK/PA 497,525$11,837,0001.93%
Parallel Advisors, LLC 1,563,974$37,207,0001.76%
Capital Impact Advisors, LLC 168,084$3,999,0001.40%
TANAKA CAPITAL MANAGEMENT INC 40,044$953,0001.21%
AJ WEALTH STRATEGIES, LLC 666,682$15,860,0001.13%
Bridge City Capital, LLC 110,512$2,629,0000.87%
Birchview Capital, LP 50,000$1,190,0000.71%
FAS Wealth Partners, Inc. 236,041$5,615,0000.58%
BURNEY CO/ 377,827$8,989,0000.44%
View complete list of CORCEPT THERAPEUTICS INC shareholders